MENU
+Compare
DGNOF
Stock ticker: OTC
AS OF
Dec 24 closing price
Price
$0.24
Change
-$0.01 (-4.00%)
Capitalization
26.05M

DGNOF stock forecast, quote, news & analysis

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy... Show more

DGNOF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for DGNOF with price predictions
Dec 24, 2025

DGNOF in upward trend: 10-day moving average crossed above 50-day moving average on December 23, 2025

The 10-day moving average for DGNOF crossed bullishly above the 50-day moving average on December 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on DGNOF as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DGNOF just turned positive on December 22, 2025. Looking at past instances where DGNOF's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

DGNOF moved above its 50-day moving average on December 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DGNOF advanced for three days, in of 95 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 81 cases where DGNOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGNOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DGNOF broke above its upper Bollinger Band on December 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DGNOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DGNOF's P/B Ratio (108.696) is slightly higher than the industry average of (21.658). P/E Ratio (0.000) is within average values for comparable stocks, (105.648). DGNOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.394). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (416.667) is also within normal values, averaging (66.378).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DGNOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.13B. The market cap for tickers in the group ranges from 708 to 37.99B. GEHC holds the highest valuation in this group at 37.99B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 3%. DTRK experienced the highest price growth at 27%, while MSPR experienced the biggest fall at -60%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -68%. For the same stocks of the Industry, the average monthly volume growth was -65% and the average quarterly volume growth was -79%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 71
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 96
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
DGNOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
7005 Taschereau Boulevard
Phone
+1 450 678-8882
Employees
42800
Web
http://www.diagnos.ca